| Literature DB >> 23115619 |
Elisabeth Sonnleitner1, Martina Valentini, Nicolas Wenner, Feth el Zahar Haichar, Dieter Haas, Karine Lapouge.
Abstract
The opportunistic human pathogen Pseudomonas aeruginosa is able to utilize a wide range of carbon and nitrogen compounds, allowing it to grow in vastly different environments. The uptake and catabolism of growth substrates are organized hierarchically by a mechanism termed catabolite repression control (Crc) whereby the Crc protein establishes translational repression of target mRNAs at CA (catabolite activity) motifs present in target mRNAs near ribosome binding sites. Poor carbon sources lead to activation of the CbrAB two-component system, which induces transcription of the small RNA (sRNA) CrcZ. This sRNA relieves Crc-mediated repression of target mRNAs. In this study, we have identified novel targets of the CbrAB/Crc system in P. aeruginosa using transcriptome analysis in combination with a search for CA motifs. We characterized four target genes involved in the uptake and utilization of less preferred carbon sources: estA (secreted esterase), acsA (acetyl-CoA synthetase), bkdR (regulator of branched-chain amino acid catabolism) and aroP2 (aromatic amino acid uptake protein). Evidence for regulation by CbrAB, CrcZ and Crc was obtained in vivo using appropriate reporter fusions, in which mutation of the CA motif resulted in loss of catabolite repression. CbrB and CrcZ were important for growth of P. aeruginosa in cystic fibrosis (CF) sputum medium, suggesting that the CbrAB/Crc system may act as an important regulator during chronic infection of the CF lung.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23115619 PMCID: PMC3480352 DOI: 10.1371/journal.pone.0044637
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Venn diagrams summarizing changes in transcript abundance in mutants affected in the CbrAB/Crc cascade.
Data are taken from Tables S1 and S2. Changes in transcript levels from LB vs. BSM-succinate cultures are shown for (A) PAO1Δcrc, (B) PAO1ΔcrcZ and (C) PAO1ΔcbrB, by comparison with the wild-type strain. Overlaps between the differentially regulated transcripts in the crc, crcZ and cbrB mutants are shown (D) for LB cultures and (E) for BSM-succinate cultures.
Selection of targets of the CbrAB/Crc system implicated by the transcriptome analysis.
| ORF | Gene | LB | BSM | Description | CA motif (location) | ||||
|
|
|
|
|
|
| ||||
| PA0755 |
| 5,9 | 2,05 |
| AAGAACAA (−25 to −18) | ||||
| PA0866 |
| 4,73 | aromatic amino acid transport protein | AACAAUAA (−33 to −12) | |||||
| PA0887 |
| −3,41 | −2,51 | −3,27 | 7,98 | 2,88 | 3,62 | acetyl-coenzyme A synthetase |
|
| PA0996 |
| −3,55 | −3,49 | −2,01 | −18,34 | −16,67 | probable coenzyme A ligase | ||
| PA0997 |
| −3,72 | −3,49 | −2,11 | −33,37 | −56,5 | PqsB protein | ||
| PA0998 |
| −3,73 | −3,89 | −2,01 | −25,21 | −40,64 | PqsC protein | ||
| PA0999 |
| −3,77 | −3,38 | −2 | −23,39 | −34,65 | 3-oxoacyl-[acyl-carrier-protein] synthase III | ||
| PA1000 |
| −2,79 | −2,58 | −2,09 | −18,62 | −22,18 | quinolone signal response protein | ||
| PA1001 |
| −3,58 | −3,28 | −2,08 | −18,69 | −23,34 | anthranilate synthase component I | ||
| PA1002 |
| −2,04 | −2,01 | −11,69 | −11,46 | anthranilate synthase component II | |||
| PA1003 |
| −2,48 | transcriptional regulator PqsR (MvfR) | ||||||
| PA1070 |
| −2,28 | −3,76 | −3,22 | branched-chain amino acid transport protein BraG | ||||
| PA1071 |
| −2,37 | −4,02 | 2,08 | −2,91 | branched-chain amino acid transport protein BraF | |||
| PA1072 |
| −2,21 | −3,11 | 2,33 | −3,05 | branched-chain amino acid transport protein BraE | |||
| PA1073 |
| −2,88 | 2,5 | −5,56 | branched-chain amino acid transport protein BraD | ||||
| PA1074 |
| −2,11 | −3,6 | 2,14 | −2,41 | branched-chain amino acid transport protein BraC | |||
| PA1342 | −2,68 | −2,38 | probable binding protein component ofABC transporter | AAUAAAAA (−33 to −26) | |||||
| PA1617 | 2,44 | probable AMP-binding enzyme |
| ||||||
| PA1894 | 5,83 | −4,24 | hypothetical protein | ||||||
| PA1895 | 4,27 | −3,07 | hypothetical protein | ||||||
| PA1984 |
| −2,76 | 3,84 | −3,37 | NAD+ dependent aldehyde dehydrogenase ExaC | ||||
| PA1985 |
| 11,34 | 8,74 | pyrroloquinoline quinone biosynthesis protein A | |||||
| PA1986 |
| 2,47 | 2,52 | pyrroloquinoline quinone biosynthesis protein B | |||||
| PA1987 |
| 3,86 | 3,7 | pyrroloquinoline quinone biosynthesis protein C | |||||
| PA1988 |
| 3,7 | 4,02 | pyrroloquinoline quinone biosynthesis protein D | |||||
| PA1989 |
| 2,72 | 2,77 | pyrroloquinoline quinone biosynthesis protein E | |||||
| PA2247 |
| −2,36 | −3,81 | 3,23 | 2-oxoisovalerate dehydrogenase (alpha subunit) | ||||
| PA2248 |
| −2,6 | −3,51 | 2-oxoisovalerate dehydrogenase (beta subunit) | |||||
| PA2249 |
| −2,48 | −3,22 | branched-chain alpha-keto acid dehydrogenase | |||||
| PA2250 |
| −2,62 | −3,07 | lipoamide dehydrogenase-Val | |||||
| PA2533 | 2,13 | probable sodium:alanine symporter | AACAAGAAUAA (−20 to −10) | ||||||
| PA3038 | −4,13 | 16,75 | 2,11 | probable porin | AAUAACAA (−7 to +1) | ||||
| PA3190 | −7,43 | −7,81 | probable binding protein component ofABC sugar transporter | AAUAACAA (−24 to −17) | |||||
| PA3366 |
| 4,65 | 2,04 | aliphatic amidase | AACAACAA (−20 to −13) | ||||
| PA3452 |
| 4,87 | 3,12 | malate:quinone oxidoreductase | |||||
| PA3570 |
| 2,23 | methylmalonate-semialdehyde dehydrogenase | AACAAUAA (−37 to −30) | |||||
| PA3875 |
| −6,01 | −4,46 | −4,79 | respiratory nitrate reductase alpha chain | AAGAAGAA (+34 to +41) | |||
| PA4139 | −3,37 | 2,87 | 4,72 | hypothetical protein | |||||
| PA4147 |
| 3,38 | transcriptional regulator AcoR | AACAACAA (−30 to −23) | |||||
| PA4150 |
| 2,77 | probable dehydrogenase E1 component | AACAACAA (−9 to −2) | |||||
| PA4151 |
| 4,1 | acetoin catabolism protein AcoB | AACAAGAA (−22 to −15) | |||||
| PA4306 |
| −2,9 | −6,66 | −8,64 | Type IVb pilin, Flp | AACAAGAA (−22 to −15) | |||
| PA4496 | −2,54 | −2,55 | 2,9 | −2,73 | −8,18 | probable binding protein component of ABC transporter | |||
| PA4500 | −3,29 | −3,94 | 2,03 | probable binding protein component of ABC transporter |
| ||||
| PA4501 |
| −2,53 | 2,64 | glycine-glutamate dipeptide porin OpdP | AACAAUAA (−37 to −30) | ||||
| PA4770 |
| 2,96 | L-lactate permease | AACAACAA (−25 to −18) | |||||
| PA4913 | 6,89 | −2,07 | probable binding protein component of ABC transporter | AACAACAA (−53 to −46) | |||||
| PA5112 |
| −2,25 | 2 | −2,23 | esterase EstA | AAAAACAA (−24 to −17) | |||
| PA5153 | −2.42 | −2.55 | 2.92 | −2.28 | probable periplasmic binding protein | ||||
| PA5167 |
| −4,35 | −4,05 | 3,37 | −6,85 | probable c4-dicarboxylate-binding protein | AAGAACAA (−20 to −13) | ||
| PA5168 |
| −2,19 | −2,12 | 6,54 | −6,4 | probable dicarboxylate transporter | AAUAAGAA (−20 to −13) | ||
| PA5169 |
| −2,41 | −2,2 | 6,72 | −10,69 | probable C4-dicarboxylate transporter | |||
| PA5220 | 2,38 | −4,08 | hypothetical protein |
| |||||
| PA5348 | 5,54 | −3,03 | probable DNA-binding protein | AACAACAA (−26 to −19) | |||||
The numbers represents ORF according to www. pseudomonas.com. [45].
Fold changes observed after growth in LB and BSM + succinate, respectively. Positive values indicate that transcripts were more abundant in the mutant than in the wild type. Negative values indicate that transcripts were less abundant in the mutant than in the wild type.
The locations of the CA-motif are given according to the start codon (A of the ATG = +1).
Fold changes of transcript abundance in Δcrc, ΔcrcZ and ΔcbrB mutants compared to wild type PAO1 in LB and BSM + succinate as determined by RT-qPCR.
| Gene | LB | BSM | ||||
|
|
|
|
|
|
| |
|
| 2.6±0.4 | −26.3±0.3 | −4.9±0.3 | 2.5±0.4 | −4.1±0.2 | −7.2±0.1 |
|
| 4.3±0.2 | −10.1±0.7 | −7.5±0.1 | 7.5±0.2 | −1.1±0.4 | 1.5±1.1 |
|
| 2.3±0.4 | −1.7±0.9 | 1.5±0.9 | 1.4±1.0 | 1.5±1.0 | 1.1±0.8 |
|
| 4.0±0.2 | −25.4±0.2 | −12.3±0.1 | 9.3±0.1 | −3.0±0.3 | −2.3±0.2 |
|
| 3.2±0.2 | 1.4±0.2 | 1.8±0.6 | 1.2±0.9 | 2.3±1.2 | −1.2±0.5 |
|
| 2.7±0.4 | −8.4±1.4 | −2.4±0.6 | −1.4±1.0 | 1.0±0.9 | 1.4±0.9 |
Values are represented as averages of 3 independent replicates for every strain.
Figure 2EstA esterase is a target of the CbrAB/Crc cascade.
β-Galactosidase activities of an estA’-‘lacZ fusion were measured in PAO1 (black diamonds), PAO1ΔcbrB (black triangles), PAO1ΔcrcZ (black squares) and PAO1Δcrc (black circles) harbouring a plasmid with a translational estA’-‘lacZ fusion (pTLestA) (A) in LB medium and (B) in BSM medium supplemented with 40 mM succinate. (C) β-Galactosidase activities derived from a translational estA’-‘lacZ fusion with a mutated CA motif (pTLestA-ΔCA) were determined in PAO1 (black diamonds), PAO1ΔcbrB (black triangles), PAO1ΔcrcZ (black squares) and PAO1Δcrc (black circles). The strains were grown in BSM supplemented with 40 mM succinate. Cell growth was monitored by measuring the optical density at 600 nm (OD600) (white symbols).
Figure 3Growth on acetate and acsA expression are under CbrAB/Crc control.
(A) Growth of PAO1 (black diamonds), PAO1ΔcbrB (black triangles), PAO1ΔcrcZ (white squares) and PAO1Δcrc (white circles) was measured in BSM supplemented with 40 mM acetate. (B) β-Galactosidase expression of a translational acsA’-‘lacZ fusion (pME10044) was monitored in PAO1 (black diamonds), PAO1ΔcbrB (black triangles), PAO1ΔcrcZ (black squares) and PAO1Δcrc (black circles). (C) Expression of a translational acsA’-‘lacZ fusion where the CA motif had been mutated (pME10045) was followed in PAO1 (black diamonds) and PAO1Δcrc (black circles). Cells were grown in BSM supplemented with 5 mM succinate and 40 mM acetate. The corresponding growth curves are shown in white symbols.
Figure 4Utilization of branched-chain amino acids is under CbrAB/Crc control.
(A) Growth of PAO1 (black diamonds), PAO1ΔcbrB (black triangles), PAO1ΔcrcZ (white squares) and PAO1Δcrc (white circles) was monitored in BSM supplemented with 23 mM leucine, 25.6 mM valine and 7.6 mM isoleucine as the sole carbon sources. β-Galactosidase activities conferred by (B) a translational bkdA1’-‘lacZ fusion (pME10049) and (C) a translational bkdR’-‘lacZ fusion (pME10048) were measured in PAO1 (black diamonds), PAO1ΔcbrB (black triangles), PAO1ΔcrcZ (black squares) and PAO1Δcrc (black circles). Cells were grown in LB supplemented with 23 mM leucine, 25.6 mM valine and 7.6 mM isoleucine. The corresponding growth curves are shown in white symbols.
Figure 5Tyrosine uptake is under CbrAB/Crc control.
(A) Growth of PAO1 (black diamonds), PAO1ΔcbrB (black triangles), PAO1ΔcrcZ (white squares) and PAO1Δcrc (white circles) was followed in BSM supplemented with 4 mM tyrosine as the sole carbon source. (B) β-Galactosidase activities conferred by the translational aroP2’-‘lacZ fusion (pME10046) were determined in PAO1 (black diamonds), PAO1ΔcbrB (black triangles), PAO1ΔcrcZ (black squares) and PAO1Δcrc (black circles). (C) Expression of a translational aroP2’-‘lacZ fusion with a mutated CA motif (pME10047) was similarly followed in PAO1 (black diamonds) and PAO1Δcrc (black circles). Cells were grown in synthetic sputum medium (SCFM). The corresponding growth curves are shown in white symbols.
Figure 6Growth of P. aeruginosa in sputum medium is under CbrAB/Crc control.
Growth curves of PAO1 (black diamonds), PAO1ΔcbrB (black triangles), PAO1ΔcrcZ (white squares) and PAO1Δcrc (white circles) were obtained in SCFM.